Viking Therapeutics (VKTX) Profit After Tax (2014 - 2026)
Viking Therapeutics' (VKTX) quarterly Profit After Tax came in at -$128.3 million in Q2 2026, down 95.72% year-over-year from -$3.0 billion in Q2 2025, and up 19.58% quarter-over-quarter from -$159.6 million in Q1 2026.
Powered by 
Analysis
Viking Therapeutics (VKTX) Profit After Tax (2014 - 2026) Analysis & Trends
Viking Therapeutics has disclosed Profit After Tax across 13 years of filings, most recently posting -$128.3 million for Q2 2026.
- In Q2 2026, Profit After Tax fell 95.72% year-over-year to -$128.3 million; the TTM figure through Jun 2026 stood at -$536.3 million (down 211.92% YoY), while the FY2025 annual figure was -$359.6 million, down 225.87% from the prior year.
- Profit After Tax came in at -$128.3 million for Q2 2026 at Viking Therapeutics, up from -$159.6 million in the prior quarter.
- In the past five years, Profit After Tax ranged from a high of -$15.9 million in Q3 2022 to a low of -$159.6 million in Q1 2026.
- Average Profit After Tax over 5 years is -$50.9 million, with a median of -$24.8 million recorded in 2023.
- Year-over-year, Profit After Tax slipped 10.68% in 2024 and tumbled 340.2% in 2025.
- Over 5 years, Profit After Tax stood at -$18.9 million in 2022, then sank by 30.19% to -$24.6 million in 2023, then sank by 45.56% to -$35.8 million in 2024, then sank by 340.2% to -$157.7 million in 2025, then grew by 18.61% to -$128.3 million in 2026.
- Per Business Quant data, the three most recent Profit After Tax figures were -$128.3 million in Q2 2026, -$159.6 million in Q1 2026, and -$157.7 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.01 Bn | 628.25 Bn | 17.26 Bn | 5.53 Bn |
| 2 | AbbVie | 468.55 Bn | 462.03 Bn | 12.70 Bn | 3.62 Bn |
| 3 | Merck | 365.49 Bn | 358.40 Bn | 12.21 Bn | -1.34 Bn |
| 4 | Novartis Ag | 272.39 Bn | 265.10 Bn | 11.24 Bn | 3.26 Bn |
| 5 | Astrazeneca | 253.18 Bn | 247.96 Bn | 12.86 Bn | 2.51 Bn |
| 6 | Amgen | 219.53 Bn | 205.54 Bn | 7.24 Bn | 2.38 Bn |
| 7 | Gilead Sciences | 187.85 Bn | 184.59 Bn | 6.22 Bn | -10.50 Bn |
| 8 | Pfizer | 160.56 Bn | 149.16 Bn | 10.94 Bn | -248.00 Mn |
| 9 | Vertex Pharmaceuticals | 130.81 Bn | 122.96 Bn | 2.84 Bn | 1.10 Bn |
| 10 | Viking Therapeutics | 4.86 Bn | 4.86 Bn | - | -128.32 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -128.32 Mn |
| Mar 31, 2026 | -159.56 Mn |
| Dec 31, 2025 | -157.66 Mn |
| Sep 30, 2025 | -90.79 Mn |
| Jun 30, 2025 | -65.56 Mn |
| Mar 31, 2025 | -45.63 Mn |
| Dec 31, 2024 | -35.82 Mn |
| Sep 30, 2024 | -24.94 Mn |
| Jun 30, 2024 | -22.92 Mn |
| Mar 31, 2024 | -28.57 Mn |
| Dec 31, 2023 | -24.61 Mn |
| Sep 30, 2023 | -22.53 Mn |
| Jun 30, 2023 | -19.65 Mn |
| Mar 31, 2023 | -19.53 Mn |
| Dec 31, 2022 | -18.90 Mn |
| Sep 30, 2022 | -15.89 Mn |
| Jun 30, 2022 | -17.67 Mn |
| Mar 31, 2022 | -16.97 Mn |
| Dec 31, 2021 | -12.74 Mn |
| Sep 30, 2021 | -13.24 Mn |
API Access
Viking Therapeutics Profit After Tax API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=profit-after-tax&ticker=VKTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "profit-after-tax", "ticker": "VKTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=profit-after-tax&ticker=VKTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();